QCM
TMO icon

Quadrant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Quadrant Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4.01M Buy
12,353
+3
+0% +$910 1.82% 13
2019
Q3 		$3.6M Buy
12,350
+160
+1% +$45.8K 1.77% 14
2019
Q2 		$3.58M Sell
12,190
-2,005
-14% -$552K 1.88% 12
2019
Q1 		$3.89M Sell
14,195
-113
-0.8% -$28.1K 2.15% 11
2018
Q4 		$3.2M Sell
14,308
-45
-0.3% -$10.6K 2.11% 14
2018
Q3 		$3.5M Sell
14,353
-45
-0.3% -$10.4K 2.22% 12
2018
Q2 		$2.98M Buy
14,398
+20
+0.1% +$4.25K 2.12% 15
2018
Q1 		$2.97M Sell
14,378
-235
-2% -$49.3K 2.18% 16
2017
Q4 		$2.77M Buy
14,613
+295
+2% +$56.5K 1.95% 20
2017
Q3 		$2.71M Buy
14,318
+455
+3% +$82.4K 2% 22
2017
Q2 		$2.42M Buy
13,863
+4,688
+51% +$787K 1.89% 24
2017
Q1 		$1.41M Buy
+9,175
New +$1.4M 1.14% 40

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Quadrant Capital Management's TMO Position: Q4 2019 in Review

Quadrant Capital Management increased its Thermo Fisher Scientific (TMO) stake by 0.02% in Q4 2019, buying an estimated $910 and bringing the position to 12,353 shares worth $4.01M. The position accounts for 1.82% of the portfolio, ranked #13.

Quadrant Capital Management first reported a position in TMO in Q1 2017 and has held it in 12 quarters since. 1,678 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

  • Quadrant Capital Management held 12,353 shares of Thermo Fisher Scientific worth $4.01M as of Q4 2019.
  • Quadrant Capital Management bought 3 Thermo Fisher Scientific shares in Q4 2019, an estimated $910.
  • Thermo Fisher Scientific made up 1.82% of Quadrant Capital Management's portfolio in Q4 2019, its #13 holding.
  • Quadrant Capital Management first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 12 quarters since.
  • 1,678 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on Quadrant Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.